Literature DB >> 24265481

Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011.

Jocelyn Moyes1, Cheryl Cohen, Marthi Pretorius, Michelle Groome, Anne von Gottberg, Nicole Wolter, Sibongile Walaza, Sumayya Haffejee, Meera Chhagan, Fathima Naby, Adam L Cohen, Stefano Tempia, Kathleen Kahn, Halima Dawood, Marietjie Venter, Shabir A Madhi.   

Abstract

BACKGROUND: There are limited data on respiratory syncytial virus (RSV) infection among children in settings with a high prevalence of human immunodeficiency virus (HIV). We studied the epidemiology of RSV-associated acute lower respiratory tract infection (ALRTI) hospitalizations among HIV-infected and HIV-uninfected children in South Africa.
METHODS: Children aged <5 years admitted to sentinel surveillance hospitals with physician-diagnosed neonatal sepsis or ALRTI were enrolled. Nasopharyngeal aspirates were tested by multiplex real-time polymerase chain reaction assays for RSV and other viruses. Associations between possible risk factors and severe outcomes for RSV infection among HIV-infected and uninfected children were examined. The relative risk of hospitalization in HIV-infected and HIV-uninfected children was calculated in 1 site with population denominators.
RESULTS: Of 4489 participants, 4293 (96%) were tested for RSV, of whom 1157 (27%) tested positive. With adjustment for age, HIV-infected children had a 3-5-fold increased risk of hospitalization with RSV-associated ALRTI (2010 relative risk, 5.6; [95% confidence interval (CI), 4.5-6.4]; 2011 relative risk, 3.1 [95% CI, 2.6-3.6]). On multivariable analysis, HIV-infected children with RSV-associated ALRTI had higher odds of death (adjusted odds ratio. 31.1; 95% CI, 5.4-179.8) and hospitalization for >5 days (adjusted odds ratio, 4.0; 95% CI, 1.5-10.6) than HIV-uninfected children.
CONCLUSION: HIV-infected children have a higher risk of hospitalization with RSV-associated ALRTI and a poorer outcome than HIV-uninfected children. These children should be targeted for interventions aimed at preventing severe RSV disease.

Entities:  

Mesh:

Year:  2013        PMID: 24265481     DOI: 10.1093/infdis/jit479

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

1.  The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016.

Authors:  Meredith L McMorrow; Stefano Tempia; Sibongile Walaza; Florette K Treurnicht; Jocelyn Moyes; Adam L Cohen; Marthi Pretorius; Orienka Hellferscee; Nicole Wolter; Anne von Gottberg; Arthemon Nguweneza; Johanna M McAnerney; Fathima Naby; Omphile Mekgoe; Marietjie Venter; Shabir A Madhi; Cheryl Cohen
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

2.  Detection of Multiple Respiratory Viruses Associated With Mortality and Severity of Illness in Children.

Authors:  Kyle J Rehder; Elizabeth A Wilson; Kanecia O Zimmerman; Coleen K Cunningham; David A Turner
Journal:  Pediatr Crit Care Med       Date:  2015-09       Impact factor: 3.624

3.  Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009.

Authors:  Stefano Tempia; Sibongile Walaza; Cecile Viboud; Adam L Cohen; Shabir A Madhi; Marietjie Venter; Johanna M McAnerney; Cheryl Cohen
Journal:  Clin Infect Dis       Date:  2014-02-23       Impact factor: 20.999

4.  Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.

Authors:  Lindsay Kim; Brian Rha; Jon S Abramson; Larry J Anderson; Carrie L Byington; Grace L Chen; John DeVincenzo; Kathryn M Edwards; Janet A Englund; Ann R Falsey; Marie R Griffin; Ruth A Karron; Karen G Martin; H Cody Meissner; Flor M Munoz; Andrew T Pavia; Pedro A Piedra; William Schaffner; Eric A F Simões; Rosalyn Singleton; H Keipp Talbot; Edward E Walsh; Jane R Zucker; Susan I Gerber
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

5.  Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

Authors:  Valeria Cagno; Manuela Donalisio; Andrea Civra; Marco Volante; Elena Veccelli; Pasqua Oreste; Marco Rusnati; David Lembo
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

6.  Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting.

Authors:  Jocelyn Moyes; Sibongile Walaza; Marthi Pretorius; Michelle Groome; Anne von Gottberg; Nicole Wolter; Sumayya Haffejee; Ebrahim Variava; Adam L Cohen; Stefano Tempia; Kathleen Kahn; Halima Dawood; Marietjie Venter; Cheryl Cohen; Shabir A Madhi
Journal:  J Infect       Date:  2017-07-01       Impact factor: 6.072

7.  The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015.

Authors:  Orienka Hellferscee; Florette K Treurnicht; Sibongile Walaza; Mignon Du Plessis; Anne Von Gottberg; Nicole Wolter; Jocelyn Moyes; Halima Dawood; Ebrahim Variava; Marthi Pretorius; Marietjie Venter; Cheryl Cohen; Stefano Tempia
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

8.  The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016.

Authors:  Meredith L McMorrow; Stefano Tempia; Sibongile Walaza; Florette K Treurnicht; Jocelyn Moyes; Adam L Cohen; Marthi Pretorius; Orienka Hellferscee; Nicole Wolter; Anne von Gottberg; Arthemon Nguweneza; Johanna M McAnerney; Fathima Naby; Omphile Mekgoe; Marietjie Venter; Shabir A Madhi; Cheryl Cohen
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079

9.  Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants.

Authors:  Cheryl Cohen; Jocelyn Moyes; Stefano Tempia; Michelle Groome; Sibongile Walaza; Marthi Pretorius; Fathima Naby; Omphile Mekgoe; Kathleen Kahn; Anne von Gottberg; Nicole Wolter; Adam L Cohen; Claire von Mollendorf; Marietjie Venter; Shabir A Madhi
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 9.703

Review 10.  Priorities for developing respiratory syncytial virus vaccines in different target populations.

Authors:  Simon B Drysdale; Rachael S Barr; Christine S Rollier; Christopher A Green; Andrew J Pollard; Charles J Sande
Journal:  Sci Transl Med       Date:  2020-03-18       Impact factor: 19.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.